Palmitoylation of Inducible Nitric-oxide Synthase at Cys-3 Is Required for Proper Intracellular Traffic and Nitric Oxide Synthesis*

A number of cell types express inducible nitric-oxide synthase (NOS2) in response to exogenous insults such as bacterial lipopolysaccharide or proinflammatory cytokines. Although it has been known for some time that the N-terminal end of NOS2 suffers a post-translational modification, its exact identification has remained elusive. Using radioactive fatty acids, we show herein that NOS2 becomes thioacylated at Cys-3 with palmitic acid. Site-directed mutagenesis of this single residue results in the absence of the radiolabel incorporation. Acylation of NOS2 is completely indispensable for intracellular sorting and ·NO synthesis. In fact, a C3S mutant of NOS2 is completely inactive and accumulates to intracellular membranes that almost totally co-localize with the Golgi marker β-cop. Likewise, low concentrations of the palmitoylation blocking agents 2-Br-palmitate or 8-Br-palmitate severely affected the ·NO synthesis of both NOS2 induced in muscular myotubes and transfected NOS2. However, unlike endothelial NOS, palmitoylation of inducible NOS is not involved in its targeting to caveolae. We have created 16 NOS2-GFP chimeras to inspect the effect of the neighboring residues of Cys-3 on the degree of palmitoylation. In this regard, the hydrophobic residue Pro-4 and the basic residue Lys-6 seem to be indispensable for palmitoylation. In addition, agents that block the endoplasmic reticulum to Golgi transit such as brefeldin A and monensin drastically reduced NOS2 activity leading to its accumulation in perinuclear areas. In summary, palmitoylation of NOS2 at Cys-3 is required for both its activity and proper intracellular localization.

[1]  C. Lowenstein,et al.  Kalirin Inhibition of Inducible Nitric-oxide Synthase* , 1999, The Journal of Biological Chemistry.

[2]  G. Garcı́a-Cardeña,et al.  Dissecting the Interaction between Nitric Oxide Synthase (NOS) and Caveolin , 1997, The Journal of Biological Chemistry.

[3]  A. Quest,et al.  Caveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  G. Warren,et al.  Dissection of the Golgi complex. I. Monensin inhibits the transport of viral membrane proteins from medial to trans Golgi cisternae in baby hamster kidney cells infected with Semliki Forest virus , 1983, The Journal of cell biology.

[5]  A. Quest,et al.  Caveolin-1-mediated post-transcriptional regulation of inducible nitric oxide synthase in human colon carcinoma cells. , 2002, Biological research.

[6]  B. Tang,et al.  A 29-Kilodalton Golgi SolubleN-Ethylmaleimide-sensitive Factor Attachment Protein Receptor (Vti1-rp2) Implicated in Protein Trafficking in the Secretory Pathway* , 1998, The Journal of Biological Chemistry.

[7]  I. Rodrı́guez-Crespo,et al.  Endothelial Nitric-oxide Synthase , 1996, The Journal of Biological Chemistry.

[8]  O. Griffith,et al.  Mammalian nitric oxide synthases. , 1999, Advances in enzymology and related areas of molecular biology.

[9]  A. Álvarez-Barrientos,et al.  Distance-dependent cellular palmitoylation of de-novo-designed sequences and their translocation to plasma membrane subdomains. , 2002, Journal of cell science.

[10]  M. Resh,et al.  Synthesis and use of iodo-fatty acid analogs. , 1995, Methods in enzymology.

[11]  P. Ortiz de Montellano,et al.  Endothelial nitric oxide synthase: modulations of the distal heme site produced by progressive N-terminal deletions. , 1997, Biochemistry.

[12]  J. Lippincott-Schwartz,et al.  Brefeldin A: insights into the control of membrane traffic and organelle structure , 1992, The Journal of cell biology.

[13]  L. Boscá,et al.  Induction of nitric oxide synthase-2 proceeds with the concomitant downregulation of the endogenous caveolin levels , 2004, Journal of Cell Science.

[14]  S Moncada,et al.  Nitric oxide synthases in mammals. , 1994, The Biochemical journal.

[15]  F. Maxfield,et al.  Rapid nonvesicular transport of sterol between the plasma membrane domains of polarized hepatic cells. , 2002, The Journal of biological chemistry.

[16]  E. Tisdale,et al.  Atypical Protein Kinase C Plays a Critical Role in Protein Transport from Pre-Golgi Intermediates* , 2003, Journal of Biological Chemistry.

[17]  M. Nakane,et al.  Inducible NO synthase II and neuronal NO synthase I are constitutively expressed in different structures of guinea pig skeletal muscle: implications for contractile function , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  P. D. de Montellano,et al.  Electron Transfer and Catalytic Activity of Nitric Oxide Synthases , 1998, The Journal of Biological Chemistry.

[19]  C. Lowenstein,et al.  An Inducible Nitric-oxide Synthase (NOS)-associated Protein Inhibits NOS Dimerization and Activity* , 1999, The Journal of Biological Chemistry.

[20]  T. Michel,et al.  The Endothelial Nitric-oxide Synthase-Caveolin Regulatory Cycle* , 1998, The Journal of Biological Chemistry.

[21]  G. Garcı́a-Cardeña,et al.  Reconstitution of an Endothelial Nitric-oxide Synthase (eNOS), hsp90, and Caveolin-1 Complex in Vitro , 2000, The Journal of Biological Chemistry.

[22]  M. Marsh,et al.  The on-off story of protein palmitoylation. , 2003, Trends in cell biology.

[23]  D. Bredt Nitric oxide signaling specificity — the heart of the problem , 2003, Journal of Cell Science.

[24]  F. Murad,et al.  Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. , 1992, Molecular pharmacology.

[25]  E. Werner,et al.  Characterization of the inducible nitric oxide synthase oxygenase domain identifies a 49 amino acid segment required for subunit dimerization and tetrahydrobiopterin interaction. , 1997, Biochemistry.

[26]  K. Aldape,et al.  Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy , 1995, Cell.

[27]  Y. Vodovotz,et al.  Vesicle membrane association of nitric oxide synthase in primary mouse macrophages. , 1995, Journal of immunology.

[28]  P. Ortiz de Montellano,et al.  Human endothelial nitric oxide synthase: expression in Escherichia coli, coexpression with calmodulin, and characterization. , 1996, Archives of biochemistry and biophysics.

[29]  C. Nathan,et al.  Nitric oxide and macrophage function. , 1997, Annual review of immunology.

[30]  G. Ringheim,et al.  Particulate and soluble forms of the inducible nitric oxide synthase are distinguishable at the amino terminus in RAW 264.7 macrophage cells. , 1995, Biochemical and biophysical research communications.

[31]  L. Berthiaume,et al.  Functional roles for fatty acylated amino-terminal domains in subcellular localization. , 1999, Molecular biology of the cell.